Danish pharmaceutical giant Novo Nordisk on Tuesday launched its anti-obesity drug Wegovy in India. This once-a-week ...

Wegovy is being made available in five dosing strengths with an easy-to-use pen device, which does away the use of syringes ...

Novo Nordisk ended its partnership with Hims & Hers on 23 June 2025, accusing the telehealth firm of selling unsafe, ...

Novo Nordisk launches Wegovy® in India, a weight management therapy reducing cardiovascular risks for people with obesity.

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

Stocks rallied and oil prices fell on Tuesday after U.S. President Donald Trump announced what appears to be a shaky ...

Novo Nordisk, the company behind blockbuster weight-loss drugs like Ozempic and Wegovy, had a deal with Hims & Hers that ...

Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week ...

U.S. stocks rallied, and the price of oil tumbled Monday on hopes that Iran will not disrupt the global flow of crude, something that would hurt economies worldwide but also its own, following the ...